Toggle navigation
Home
Search
Services
Blog
Contact
About
Antihormonal to Leukemia - Modified Cytokine Receptor
Hankins, W D.
Proed, Inc., Gaithersburg, MD, United States
Search 164 grants from W Hankins
Search grants from Proed, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Mechanisms of particulate matter driven infant respiratory disease
Cortical Excitability: Biomarker and Endophenotype in Combat Related PTSD
Eicosanoids Blood Vessels and Hypertension
Polycystic Ovary Syndrome Changes After Gnrh Agonist Ovarian Suppression
The Cold Gas History of the Universe
Recently added grants:
Aneuploidy and Acquired Antifungal Drug Resistance in Candida species
Targeting ALK through Degradation and Allosteric Inhibitors
Understanding Spatially Regulated Tumor-Inhibitory Function of Profilin-1 and its Deregulation in Breast Cancer
Understanding how adrenergic signaling influences immune contexture of tumors and the efficacy of checkpoint inhibitors
Metabolic Constraints on Cancer Cell Proliferation
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
5R44CA061621-04
Application #
2102360
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
1994-04-04
Project End
1998-02-28
Budget Start
1996-03-01
Budget End
1998-02-28
Support Year
4
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Proed, Inc.
Department
Type
DUNS #
City
Gaithersburg
State
MD
Country
United States
Zip Code
20877
Related projects
NIH 1996
R44 CA
Antihormonal to Leukemia - Modified Cytokine Receptor
Hankins, W D. / Proed, Inc.
NIH 1995
R44 CA
Antihormonal to Leukemia - Modified Cytokine Receptor
Hankins, W D. / Proed, Inc.
Comments
Be the first to comment on this grant